[
  {
    "ts": "2025-06-21T12:21:00+00:00",
    "headline": "GE HealthCare drives innovation in theranostics with latest technological advances",
    "summary": "CHICAGO, June 21, 2025--At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with automated zero-click pre-processingi – an AI-powered innovation to help aid physician decision making and therapy response moni",
    "url": "https://finance.yahoo.com/news/ge-healthcare-drives-innovation-theranostics-122100992.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "fdc7daac-307a-33cc-a0f8-098215b80530",
      "content": {
        "id": "fdc7daac-307a-33cc-a0f8-098215b80530",
        "contentType": "STORY",
        "title": "GE HealthCare drives innovation in theranostics with latest technological advances",
        "description": "",
        "summary": "CHICAGO, June 21, 2025--At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare’s MIM Software introduces LesionID Pro with automated zero-click pre-processingi – an AI-powered innovation to help aid physician decision making and therapy response moni",
        "pubDate": "2025-06-21T12:21:00Z",
        "displayTime": "2025-06-21T12:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8",
          "originalWidth": 6570,
          "originalHeight": 2242,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UOpdISFJRBseLRecByHW5Q--~B/aD0yMjQyO3c9NjU3MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8.cf.webp",
              "width": 6570,
              "height": 2242,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v.WxRVC6PCgG_1HClfoGBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6e30f8456a22664519ae6745e0ac6ba8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-drives-innovation-theranostics-122100992.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-drives-innovation-theranostics-122100992.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]